Tags

Type your tag names separated by a space and hit enter

[Surgical treatment of syringomyelia associated with Chiari malformation].
No Shinkei Geka. 1988; 16(5 Suppl):631-8.NS

Abstract

There is now a controversy about the methods of surgical treatment in syringomyelia associated with Chiari malformation. In this report, the authors emphasize that syringosubarachnoid shunt is effective as a surgical procedure or syringomyelia associated with Chiari malformation. From 1982 to 1986, 17 patients with syringomyelia associated with Chiari malformation were surgically treated. Seventeen patients underwent 22 operative procedures for syringomyelia. Syringosubarachnoid shunt was used in eighteen patients, foramen magnum decompression with syringosubarachnoid shunt in one, foramen magnum decompression with terminal syringostomy in one, terminal syringostomy in one, and ventriculoperitoneal shunt in one. The average postoperative follow up period was 2 years and 3 months, from 4 months to 4 years and 11 months. Thirteen out of 17 patients showed neurological improvement and 3 patients were neurologically unchanged. In one patient, the symptoms deteriorated. Syringosubarachnoid shunt is an effective therapeutic procedure for the patient with syringomyelia associated with Chiari malformation. We think that shunt malfunction by arachnoiditis after operation could be prevented by inserting the shunt tube into the subarachnoid space and closing the arachnoid membrane.

Authors+Show Affiliations

Isu T
Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan.
Iwasaki Y
No affiliation info available
Akino M
No affiliation info available
Abe H
No affiliation info available

MeSH

AdolescentAdultArnold-Chiari MalformationCerebrospinal Fluid ShuntsChildFemaleHumansMaleMiddle AgedSyringomyelia

Pub Type(s)

English Abstract
Journal Article

Language

jpn

PubMed ID

3399018

Citation

Isu, T, et al. "[Surgical Treatment of Syringomyelia Associated With Chiari Malformation]." No Shinkei Geka. Neurological Surgery, vol. 16, no. 5 Suppl, 1988, pp. 631-8.
Isu T, Iwasaki Y, Akino M, et al. [Surgical treatment of syringomyelia associated with Chiari malformation]. No Shinkei Geka. 1988;16(5 Suppl):631-8.
Isu, T., Iwasaki, Y., Akino, M., & Abe, H. (1988). [Surgical treatment of syringomyelia associated with Chiari malformation]. No Shinkei Geka. Neurological Surgery, 16(5 Suppl), 631-8.
Isu T, et al. [Surgical Treatment of Syringomyelia Associated With Chiari Malformation]. No Shinkei Geka. 1988;16(5 Suppl):631-8. PubMed PMID: 3399018.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Surgical treatment of syringomyelia associated with Chiari malformation]. AU - Isu,T, AU - Iwasaki,Y, AU - Akino,M, AU - Abe,H, PY - 1988/1/1/pubmed PY - 1988/1/1/medline PY - 1988/1/1/entrez SP - 631 EP - 8 JF - No shinkei geka. Neurological surgery JO - No Shinkei Geka VL - 16 IS - 5 Suppl N2 - There is now a controversy about the methods of surgical treatment in syringomyelia associated with Chiari malformation. In this report, the authors emphasize that syringosubarachnoid shunt is effective as a surgical procedure or syringomyelia associated with Chiari malformation. From 1982 to 1986, 17 patients with syringomyelia associated with Chiari malformation were surgically treated. Seventeen patients underwent 22 operative procedures for syringomyelia. Syringosubarachnoid shunt was used in eighteen patients, foramen magnum decompression with syringosubarachnoid shunt in one, foramen magnum decompression with terminal syringostomy in one, terminal syringostomy in one, and ventriculoperitoneal shunt in one. The average postoperative follow up period was 2 years and 3 months, from 4 months to 4 years and 11 months. Thirteen out of 17 patients showed neurological improvement and 3 patients were neurologically unchanged. In one patient, the symptoms deteriorated. Syringosubarachnoid shunt is an effective therapeutic procedure for the patient with syringomyelia associated with Chiari malformation. We think that shunt malfunction by arachnoiditis after operation could be prevented by inserting the shunt tube into the subarachnoid space and closing the arachnoid membrane. SN - 0301-2603 UR - https://www.unboundmedicine.com/medline/citation/3399018/[Surgical_treatment_of_syringomyelia_associated_with_Chiari_malformation]_ L2 - http://www.diseaseinfosearch.org/result/6981 DB - PRIME DP - Unbound Medicine ER -